Portola Finally Gets FDA OK For Factor Xa Antidote AndexXa

It has taken a while and there were concerns that another trial may be needed before approval but AndexXa has got the green light in the US as a reversal agent for Eliquis and Xarelto. It comes with a warning and post-marketing commitments but Portola has very high hopes.

Congratulations
Portola gets good news from the FDA • Source: Shutterstock

Fears that Portola Pharmaceuticals Inc.'s AndexXa (andexanet alfa) would face further years of delay in getting approved in the US as an antidote for Factor Xa anticoagulants are unfounded now that the FDA has given the green light, albeit with a black box warning.

It has been a long time coming but the agency has granted approval for AndexXa, making it the only antidote...

Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Blood and Clotting

More from Therapeutic Category